|
FDA Antimicrobial Drugs Advisory Committee (FDA AMDAC)
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIAID
|
Discuss new drug application (NDA) 215596, for maribavir oral tablets, submitted by Takeda Pharmaceuticals USA, Inc., for the treatment of adults with post-transplant cytomegalovirus infection and/or disease, including infections resistant and/or refractory to ganciclovir, valganciclovir, cidofovir, or foscarnet.
|
|
FDA Collaboration - Psilocybin Research
|
Research Initiative
|
FDA
|
CC
|
The group is working on research that might gauge the effectiveness of psilocybin for pain management and use in other facets of palliative care.
|
|
FDA Microbiology Devices Panel of the Medical Devices Advisory Committee
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIAID
|
This Committee provides expertise in the evaluation of evidence submitted by pharmaceutical companies to the Food and Drug Administration (FDA) for drug approval.
|
|
FDA-NIH Joint Leadership Council
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
OD/OSP, NCI, NHLBI, NIAID, NIDA, NIDDK, NINDS, OD/IMOD, OD/OER
|
Facilitates leadership-level development of mutual priorities between both Department of Health and Human Services (HHS) operating divisions.
|
|
FDA/NIMH Points of Contact Working Group Meeting - Drugs
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIMH
|
Food and Drug Administration (FDA) and National Institute of Mental Health (NIMH) representatives meet quarterly to discuss issues of mutual interest related to the development and clinical trials of pharmacologic therapeutic interventions.
|
|
Feasibility Study: Maternal Health Care of Pregnant Women in Custody, Expert Panel
|
Committee, Work group, Advisory group, or Task Force
|
HRSA
|
NICHD
|
Convened by Abt Associates on behalf of the U.S. Department of Justice
|
|
Federal Cannabis Partners
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, SAMHSA
|
NIDA, NCI
|
The Federal Cannabis Partners working group meets quarterly to discuss issues of interest related to cannabis and public health and to foster collaborations across HHS and other agencies.
|
|
Federal Cervical Cancer Collaboration
|
Resource Development
|
HRSA
|
NCI
|
The FCCC is a collaboration between HRSA, NCI, CDC, and NIH Office of Women's Health to accelerate uptake of new cervical screening and management recommendations and HPV vaccination. The FCCC is hosting roundtable discussions with several groups in 2022 and will develop toolkits, particularly to support safety-net settings of care.
|
|
Federal Consortium on the Substance Abusing Offender
|
Committee, Work group, Advisory group, or Task Force
|
SAMHSA
|
NIDA
|
Coordination of approximately a dozen agencies that work with substance abusing offenders. Staff meet by phone quarterly to provide updates on projects and initiatives at their agencies at the intersection of substance use and justice.
|
|
Federal Dietary Reference Intakes Steering Committee
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, OASH
|
OD/DPCPSI/ONR, NHLBI, NIDDK, OD/DPCPSI
|
This Dietary Reference Intakes subcommittee reports to the Interagency Committee on Human Nutrition Research (ICHRN) to provide oversight on the process used to establish the Dietary Reference Intakes. These values serve as a basis for many federal nutrition programs and policies.
|